Skip to main content
Livermore
Livermore
ZHEN

Ikarian Capital, LLC

SEC CIK
0001778253
Latest filing
Aug 14, 2026

CMMB holding history

Chemomab Therapeutics Ltd. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CMMB overviewAll 13F holders of CMMBFull Q2 2026 holdings

Shares (Q2 2026)
51,793
Value
$83.9K
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of CMMB by Ikarian Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202651,793$83.9K<0.1%00.0%UnchangedHolders
Q1 202651,793$81.3K<0.1%00.0%UnchangedHolders
Q4 202551,793$85.5K<0.1%−1,469−2.8%ReducedHolders
Q3 202553,262$140.1K<0.1%00.0%UnchangedConverted for a 1-for-4 splitHolders
Q2 2025213,052$247.1K0.1%00.0%UnchangedHolders
Q1 2025213,052$232.2K0.1%00.0%UnchangedHolders
Q4 2024213,052$385.6K0.1%−340−0.2%ReducedHolders
Q3 2024213,392$335.0K0.1%00.0%UnchangedHolders
Q2 2024213,392$196.3K0.1%00.0%UnchangedHolders
Q1 2024213,392$166.2K<0.1%00.0%UnchangedHolders
Q4 2023213,392$108.8K<0.1%00.0%UnchangedHolders
Q3 2023213,392$191.0K0.1%00.0%UnchangedHolders
Q2 2023213,392$279.5K0.1%−23,317−9.9%ReducedHolders
Q1 2023236,709$342.1K0.1%−76,683−24.5%ReducedHolders
Q4 2022313,392$1.00M0.4%+67,496+27.4%AddedHolders
Q3 2022245,896$612.0K0.3%−22,208−8.3%ReducedHolders
Q2 2022268,104$992.0K0.4%00.0%UnchangedHolders
Q1 2022268,104$1.29M0.4%+2,840+1.1%AddedHolders
Q4 2021265,264$1.83M0.5%−20,000−7.0%ReducedHolders
Q3 2021285,264$3.16M0.7%−5,270−1.8%ReducedHolders
Q2 2021290,534$5.53M1.0%+290,534NewHolders